The level of serum total bile acid is related to atherosclerotic lesions, prognosis and gut Lactobacillus in acute coronary syndrome patients

References

• Zheng X, Chen T, Jiang R, et al. Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism. Cell Metab. 2021;33(4):1–13. doi:10.1016/j.cmet.2020.11.017.
   PubMed Web of Science ®Google Scholar
• Wahlström A, Sayin SI, Marschall HU, et al. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24(1):41–50. doi:10.1016/j.cmet.2016.05.005.
   PubMed Web of Science ®Google Scholar
• De Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab. 2013;17(5):657–669. doi:10.1016/j.cmet.2013.03.013.
   PubMed Web of Science ®Google Scholar
• Murakami S, Fujita M, Nakamura M, et al. Taurine ameliorates cholesterol metabolism by stimulating bile acid production in high-cholesterol-fed rats. Clin Exp Pharmacol Physiol. 2016;43(3):372–378. doi:10.1111/1440-1681.12534.
   PubMed Web of Science ®Google Scholar
• Zhang B, Kuipers F, de Boer JF, et al. Modulation of bile acid metabolism to improve plasma lipid and lipoprotein profiles. J Clin Med. 2021;11(1):4. doi:10.3390/jcm11010004.
   PubMed Web of Science ®Google Scholar
• Alder M, Bavishi A, Zumpf K, et al. A meta-analysis assessing additional LDL-C reduction from addition of a bile acid sequestrant to statin therapy. Am J Med. 2020;133(11):1322–1327. doi:10.1016/j.amjmed.2020.03.056.
   PubMed Web of Science ®Google Scholar
• Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk [published correction appears in Eur Heart J. 2020;41(44):4255]. Eur Heart J. 2020;41(1):111–188. doi:10.1093/eurheartj/ehz455.
   PubMed Web of Science ®Google Scholar
• Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomized, clinical SYNTAX trial. Lancet. 2013;381(9867):629–638. doi:10.1016/S0140-6736(13)60141-5.
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Harris SC, Bhowmik S, et al. Consequences of bile salt biotransformations by intestinal bacteria [published correction appears in Gut Microb. 2016;7(3):262]. Gut Microbes. 2016;7(1):22–39. doi:10.1080/19490976.2015.1127483.
   PubMed Web of Science ®Google Scholar
• Kriaa A, Bourgin M, Potiron A, et al. Microbial impact on cholesterol and bile acid metabolism: current status and future prospects. J Lipid Res. 2019;60(2):323–332. doi:10.1194/jlr.R088989.
   PubMed Web of Science ®Google Scholar
• Lye HS, Rusul G, Liong MT. Mechanisms of cholesterol removal by lactobacilli under conditions that mimic the human gastrointestinal tract. Int Dairy J. 2010;20(3):169–175. doi:10.1016/j.idairyj.2009.10.003.
   Web of Science ®Google Scholar
• Zhou X, Li J, Guo J, et al. Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction. Microbiome. 2018;6(1):66. doi:10.1186/s40168-018-0441-4.
   PubMedGoogle Scholar
• Lam V, Su J, Koprowski S, et al. Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J. 2012;26(4):1727–1735. doi:10.1096/fj.11-197921.
   PubMed Web of Science ®Google Scholar
• Haghikia A, Li XS, Liman TG, et al. Gut microbiota-dependent trimethylamine N-oxide predicts risk of cardiovascular events in patients with stroke and is related to proinflammatory monocytes. Arterioscler Thromb Vasc Biol. 2018;38(9):2225–2235. doi:10.1161/ATVBAHA.118.311023.
   PubMed Web of Science ®Google Scholar
• Gao J, Yan KT, Wang JX, et al. Gut microbial taxa as potential predictive biomarkers for acute coronary syndrome and post-STEMI cardiovascular events. Sci Rep. 2020;10(1):2639. doi:10.1038/s41598-020-59235-5.
   PubMed Web of Science ®Google Scholar
• Gao J, Wang J, Zhao LL, et al. Gut Lactobacillus level is a predictive marker for coronary atherosclerotic lesions progress and prognosis in patients with acute coronary syndrome. Front Cell Infect Microbiol. 2021;11:687827. doi:10.3389/fcimb.2021.687827.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang J, Lin X, et al. DCA-TGR5 signaling activation alleviates inflammatory response and improves cardiac function in myocardial infarction. J Mol Cell Cardiol. 2021;151:3–14. doi:10.1016/j.yjmcc.2020.10.014.
   PubMed Web of Science ®Google Scholar
• Fan Y, Li Y, Chen Y, et al. Comprehensive metabolomic characterization of coronary artery diseases. J Am Coll Cardiol. 2016;68(12):1281–1293. doi:10.1016/j.jacc.2016.06.044.
   PubMed Web of Science ®Google Scholar
• Babu AF, Koistinen VM, Turunen S, et al. Identification and distribution of sterols, bile acids, and acylcarnitines by LC–MS/MS in humans, mice, and Pigs-A qualitative analysis. Metabolites. 2022;12(1):49. doi:10.3390/metabo12010049.
   PubMed Web of Science ®Google Scholar
• Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the Management of Acute Myocardial Infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–177. doi:10.1093/eurheartj/ehx393.
   PubMed Web of Science ®Google Scholar
• Lee SH, Yun Y, Kim SJ, et al. Association between cigarette smoking status and composition of gut microbiota: population-based cross-sectional study. J Clin Med. 2018;7(9):282. doi:10.3390/jcm7090282.
   PubMed Web of Science ®Google Scholar
• Martino C, Zaramela LS, Gao B, et al. Acetate reprograms gut microbiota during alcohol consumption. Nat Commun. 2022;13(1):4630. doi:10.1038/s41467-022-31973-2.
   PubMed Web of Science ®Google Scholar
• Heilig HG, Zoetendal EG, Vaughan EE, et al. Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol. 2002;68(1):114–123. doi:10.1128/AEM.68.1.114-123.2002.
   PubMed Web of Science ®Google Scholar
• Nadkarni MA, Martin FE, Jacques NA, et al. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology. 2002;148(Pt 1):257–266. doi:10.1099/00221287-148-1-257.
   PubMedGoogle Scholar
• Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252–7259. doi:10.1158/1078-0432.CCR-04-0713.
   PubMed Web of Science ®Google Scholar
• Hayes AF. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. New York: Guilford Press; 2018.
   Google Scholar
• Sousa-Uva M, Neumann FJ, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 2019;55(1):4–90. doi:10.1093/ejcts/ezy289.
   PubMed Web of Science ®Google Scholar
• Thuijs DJFM, Kappetein AP, Serruys PW, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial [published correction appears in Lancet. 2020;395(10227):870]. Lancet. 2019;394(10206):1325–1334. doi:10.1016/S0140-6736(19)31997-X.
   PubMed Web of Science ®Google Scholar
• Weiwei C, Runlin G, Lisheng L, et al. Outline of the report on cardiovascular diseases in China, 2014. Eur Heart J Suppl. 2016;18(Suppl. F):F2–F11. doi:10.1093/eurheartj/suw030.
   PubMed Web of Science ®Google Scholar
• Han Z, Lai L, Pu Z, et al. A nomogram to predict patients with obstructive coronary artery disease: development and validation. Cardiovasc Innov Appl. 2021;5(4):245–255. doi:10.15212/CVIA.2021.0001.
   Web of Science ®Google Scholar
• Charach G, Argov O, Geiger K, et al. Diminished bile acids excretion is a risk factor for coronary artery disease: 20-year follow up and long-term outcome. Therap Adv Gastroenterol. 2018;11:1756283X17743420. doi:10.1177/1756283X17743420.
   PubMed Web of Science ®Google Scholar
• Li W, Shu S, Cheng L, et al. Fasting serum total bile acid level is associated with coronary artery disease, myocardial infarction and severity of coronary lesions. Atherosclerosis. 2020;292:193–200. doi:10.1016/j.atherosclerosis.2019.11.026.
   PubMed Web of Science ®Google Scholar
• Malik M, Suboc TM, Tyagi S, et al. Lactobacillus plantarum 299v supplementation improves vascular endothelial function and reduces inflammatory biomarkers in men with stable coronary artery disease. Circ Res. 2018;123(9):1091–1102. doi:10.1161/CIRCRESAHA.118.313565.
   PubMed Web of Science ®Google Scholar
• Lam V, Su J, Koprowski S, et al. Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J. 2012;26(4):1727–1735. doi:10.1096/fj.11-197921
   Google Scholar
• Sayin SI, Wahlström A, Felin J, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013;17(2):225–235. doi:10.1016/j.cmet.2013.01.003.
   PubMed Web of Science ®Google Scholar
• Larabi AB, Masson HLP, Bäumler AJ. Bile acids as modulators of gut microbiota composition and function. Gut Microbes. 2023;15(1):2172671. doi:10.1080/19490976.2023.2172671.
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen K, Li F, et al. Probiotic Lactobacillus rhamnosus GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice. Hepatology. 2020;71(6):2050–2066. doi:10.1002/hep.30975.
   PubMed Web of Science ®Google Scholar
• Zhai Q, Liu Y, Wang C, et al. Lactobacillus plantarum CCFM8661 modulates bile acid enterohepatic circulation and increases lead excretion in mice. Food Funct. 2019;10(3):1455–1464. doi:10.1039/c8fo02554a.
   PubMed Web of Science ®Google Scholar
• Li X, Xiao Y, Huang Y, et al. Lactobacillus gasseri RW2014 ameliorates hyperlipidemia by modulating bile acid metabolism and gut microbiota composition in rats. Nutrients. 2022;14(23):4945. doi:10.3390/nu14234945.
   PubMed Web of Science ®Google Scholar
• Rivard AL, Steer CJ, Kren BT, et al. Administration of tauroursodeoxycholic acid (TUDCA) reduces apoptosis following myocardial infarction in rat. Am J Chin Med. 2007;35(2):279–295. doi:10.1142/S0192415X07004813.
   PubMed Web of Science ®Google Scholar
• Gan XT, Ettinger G, Huang CX, et al. Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat. Circ Heart Fail. 2014;7(3):491–499. doi:10.1161/CIRCHEARTFAILURE.113.000978.
   PubMed Web of Science ®Google Scholar